CD44 and neoplasm: In fact, a subpopulation of cancer cells enriched as tumor-initiating cells with the antigenic phenotype CD44+/CD24- has been increasingly found in metastatic breast cancer, in comparison to the majority of carcinoma cells, which are CD44-/CD24+ phenotype [20–23].